DBV Technologies | DBVT - Ebit





Ebit Cambiamento Data
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
DBV Technologies USD -34.28M 6.83M 2025-09
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Galectin Therapeutics USD -9.17M 163K 2023-09
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12